148 related articles for article (PubMed ID: 30965023)
1. Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
Radhakrishnan R; Pooja D; Kulhari H; Gudem S; Ravuri HG; Bhargava S; Ramakrishna S
Chem Phys Lipids; 2019 Nov; 224():104770. PubMed ID: 30965023
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
3. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
4. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
[TBL] [Abstract][Full Text] [Related]
5.
Gibbens-Bandala B; Morales-Avila E; Ferro-Flores G; Santos-Cuevas C; Meléndez-Alafort L; Trujillo-Nolasco M; Ocampo-García B
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110043. PubMed ID: 31546458
[TBL] [Abstract][Full Text] [Related]
6. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
[TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery.
Wu S; Yang X; Luo F; Wu T; Xu P; Zou M; Yan J
J Nanobiotechnology; 2018 Nov; 16(1):90. PubMed ID: 30424776
[TBL] [Abstract][Full Text] [Related]
8. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
[TBL] [Abstract][Full Text] [Related]
9. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel/epigallocatechin gallate coloaded liposome: a synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells.
Ramadass SK; Anantharaman NV; Subramanian S; Sivasubramanian S; Madhan B
Colloids Surf B Biointerfaces; 2015 Jan; 125():65-72. PubMed ID: 25437065
[TBL] [Abstract][Full Text] [Related]
12. Delivery of green tea catechin and epigallocatechin gallate in liposomes incorporated into low-fat hard cheese.
Rashidinejad A; Birch EJ; Sun-Waterhouse D; Everett DW
Food Chem; 2014 Aug; 156():176-83. PubMed ID: 24629955
[TBL] [Abstract][Full Text] [Related]
13. Multi-ligand modified PC@DOX-PA/EGCG micelles effectively inhibit the growth of ER
Wang X; He J; Jiang S; Gao Y; Zhang LK; Yin L; You R; Guan YQ
J Mater Chem B; 2022 Jan; 10(3):418-429. PubMed ID: 34940773
[TBL] [Abstract][Full Text] [Related]
14. Effect of liposome encapsulation of tea catechins on their accumulation in basal cell carcinomas.
Fang JY; Lee WR; Shen SC; Huang YL
J Dermatol Sci; 2006 May; 42(2):101-9. PubMed ID: 16423506
[TBL] [Abstract][Full Text] [Related]
15. Honokiol nanoparticles based on epigallocatechin gallate functionalized chitin to enhance therapeutic effects against liver cancer.
Tang P; Sun Q; Yang H; Tang B; Pu H; Li H
Int J Pharm; 2018 Jul; 545(1-2):74-83. PubMed ID: 29715531
[TBL] [Abstract][Full Text] [Related]
16. "Stealth and Fully-Laden" Drug Carriers: Self-Assembled Nanogels Encapsulated with Epigallocatechin Gallate and siRNA for Drug-Resistant Breast Cancer Therapy.
Ding J; Liang T; Min Q; Jiang L; Zhu JJ
ACS Appl Mater Interfaces; 2018 Mar; 10(12):9938-9948. PubMed ID: 29436217
[TBL] [Abstract][Full Text] [Related]
17. Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery.
Yongvongsoontorn N; Chung JE; Gao SJ; Bae KH; Yamashita A; Tan MH; Ying JY; Kurisawa M
ACS Nano; 2019 Jul; 13(7):7591-7602. PubMed ID: 31262169
[TBL] [Abstract][Full Text] [Related]
18. Target challenging-cancer drug delivery to gastric cancer tissues with a fucose graft epigallocatechin-3-gallate-gold particles nanocomposite approach.
Yuan X; He Y; Zhou G; Li X; Feng A; Zheng W
J Photochem Photobiol B; 2018 Jun; 183():147-153. PubMed ID: 29705507
[TBL] [Abstract][Full Text] [Related]
19. The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
Hsieh DS; Wang H; Tan SW; Huang YH; Tsai CY; Yeh MK; Wu CJ
Biomaterials; 2011 Oct; 32(30):7633-40. PubMed ID: 21782236
[TBL] [Abstract][Full Text] [Related]
20. Enhanced uptake and transport of (+)-catechin and (-)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells.
Song Q; Li D; Zhou Y; Yang J; Yang W; Zhou G; Wen J
Int J Nanomedicine; 2014; 9():2157-65. PubMed ID: 24855353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
